ClusterOS Diagnostic Profile
Greater Glasgow Life Sciences
Greater Glasgow Life Sciences runs on 95 evidence items (Greater Glasgow Life Sciences UKRI grants: 282 grants, £315m total, 41 distin). The diagnostic resolves a Extraction-Narrative configuration at HIGH confidence.
Value extraction events generate narrative about ecosystem success; narrative legitimises continued extraction by framing it as ecosystem contribution; uncertainty about whether extraction is harmful absorbed by the success narrative.
Intermediaries produce narrative about their facilitation role; narrative legitimises intermediary existence and funding; uncertainty about direct coupling absorbed by narrative rather than demonstration.
"If ecosystem reports (e.g., from Scottish Enterprise, Life Sciences Scotland, or GCID) separated "value created" metrics (spin-offs formed, equity raised, patents filed) from "value retained" metrics (companies headquartered in cluster, employment in cluster, procurement from cluster suppliers), it might reduce the system's ability to absorb success and uncertainty signals through aggregated success narratives without making the distinction between extraction and retention visible and...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.